Picture of Cambium Bio logo

CMB — Cambium Bio News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Regeneus Granted New Patent To Target Pain In Japan

Feb 9 (Reuters) - Regeneus Ltd  RGS.AX :
    * REGENEUS TO BE GRANTED NEW PATENT TO TARGET PAIN IN JAPAN
    * JAPANESE PATENT OFFICE DECIDED TO GRANT CO NEW KEY PATENT
COVERING USE OF ITS LEAD STEM CELL TECHNOLOGY PROGENZA

Source: https://bit.ly/3tA9nJX
Further company coverage:  RGS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cambium Bio

See all news